0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight ankylosing spondylitis bekhterevs disease global api manufacturers marketed phase.Your search for "" gave back 1533061 results.
The global Systemic Autoimmune Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Summary The Musculoskeletal Disorders Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Publisher' newest research report, the “Systemic Autoimmune Disease Diagnostics Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global Systemic Autoimmune Disease Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Summary HeyReport estimates that the Rheumatology Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Etanercept market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary The Rheumatology Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Summary The Etanercept market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year...
Catalog:
HYR
February 2021
Price: USD 2,000.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global PDE 4 Inhibitors market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
TNF Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about TNF Antibodies –Biosimilars and Biosuperiors provides...
Catalog:
La Merie Publishing
March 2014
Price: USD 551.00
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global Humira...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Autoimmune Drugs market size was valued at US$ 2193.5 million in 2023. With growing demand in downstream market, the Autoimmune Drugs is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
